Register for some of these informative online events happening throughout the month of January. Photo via Getty Images

It's a whole new year, but Houston is cranking out the same great business and innovation-focused events.

Here's a roundup of virtual events not to miss this month — from workshops and webinars to summits and pitch parties. Note: This post will be updated to add more events.

January 6 — The New Relief Package - Explained by SBA

With the passage of the Consolidated Appropriations Act 2021, a $2.3 trillion spending bill, a new round of stimulus funding will soon be available. Join the Houston Asian Chamber of Commerce for a discussion with Tim Jeffcoat, Director of the U.S. Small Business Administration in Houston as we navigate what this means for small businesses and how you can apply for Paycheck Protection Programs and Economic Injury Disaster Loans as well as other SBA loans.

The event is on Wednesday, January 6, at 10 am. It's free and can be accessed online. Click here to register.

January 13 — How to Change Careers: Oil and Gas

The way we work is changing. Some might feel a stronger push to make a change. If you are looking for a career transition, I invite you to explore innovative career paths in energy and Oil & Gas. How can you pursue a career change during uncertainty? By leaning into the changes happening in the world. We are at a crossroads and many things will now evolve - let's contribute our skills, passion and drive to participate in this evolution.

The General Assembly event is on Wednesday, January 13, at noon. It's free and can be accessed online. Click here to register.

January 13 — Saudi Aramco Energy Ventures - Investment Directions in the new Energy Landscape

As 2021 begins, the world has seen dramatic volatility in the entire energy landscape, with demand for hydrocarbons seeing precipitous drops, while renewable energy investment has increased, as many countries across the world prioritize meeting the COP21 agreement and other ESG concerns. Jim Sledzik is the Managing Director of the North America team of Saudi Aramco Energy Ventures will discuss current and ongoing investment directions and themes for SAEV. He'll give insight to aspiring entrepreneurs on what are investable propositions for SAEV across the entire energy landscape.

The event is on Wednesday, January 13, at 4 pm. It's free and can be accessed online. Click here to register.

January 14 — Plaza Tec: How We Made it Big

Learn from Latinx founders about their experiences accessing funding, using technology to grow/pivot, and hurdles they have overcome. This event is designed by The Ion to give you a set of tools and pathways to help you navigate your business and take advantage of technology to help you grow. Every business has failures. No business succeeds without some change of plan. Join us for a founders focus event on "How We Made It Big" to learn how to use resources available in the tech and innovation ecosystem to help your business grow.

The event is on Thursday, January 14, at noon. It's free and can be accessed online. Click here to register.

January 14 — Intro to Fundraising & Ask Me Anything: Defense Edition with Craig Cummings

Join Capital Factory virtually to hear an overview from experienced entrepreneurs, venture capitalists, and angel investors at Intro to Fundraising & Ask Me Anything: Defense Edition. Get a chance to introduce yourself and ask any questions on funding and other related topics.

The event is on Thursday, January 14, at 2 pm. It's free and can be accessed online. Click here to register.

January 16 — Enventure Basecamp - Business Building Workshop

Enventure's community-driven business building Basecamp series returns this October to support a local innovator with their healthcare venture. This event will be virtual. All experience levels are welcome, this is an excellent learning and networking opportunity.

The event is on Saturday, January 16, at 9 am. It's free and can be accessed online. Click here to register.

January 22 — The Village School's Innovation Day

The Village School's annual Innovation Day is a celebration of ideas and solutions created by students to tackle today's most pressing problems — such as designing solutions to live on Mars in zero gravity, composing and scoring music through computer software and high school entrepreneurs who are running their own businesses.

The event is on Friday, January 22, at 9 am. It's free and can be accessed online. Click here to register.

January 21 — Angel Investing 101 Series | Urban Capital Network

Join Urban Capital Network (UCN) and their special guest(s) who will talk about and share their experiences in early-stage investing. Target audience includes current and future investors interested in learning about early-stage angel investing and hearing first-hand experiences from talented and seasoned panelists, as well as entrepreneurs interested in learning more about the capital raising process and lifecycle.

The event is on Thursday, January 21, at 5:30 pm. It's free and can be accessed online. Click here to register.

January 27 — Houston Startup Showcase

The Houston Startup Showcase is a flagship event from The Ion, formerly known as Demo Day. This event will allow for developing companies to receive feedback from subject matter experts and showcase their successes thus far. The event is a year-long series of monthly pitch competitions, and results in a final winner to close the series in November. Companies are encouraged to apply online to pitch.

The event is on Wednesday, January 27, at 6 pm. It's free and can be accessed online. Click here to register.

January 28 — Building a More Inclusive Startup

Starting off with the first of a series of four DEI workshops, this interactive event, co-hosted by Greentown Labs and Aleria Research, will provide you actionable frameworks, tools, and resources to empower your team to build a more inclusive startup.

The event is on Thursday, January 28, at 11 am. It's free and can be accessed online. Click here to register.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.